Autopsy report · NCT03645681
Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure
Cause of deathOther
“Concerns around a high rate of thrombosis associated with kinking between the pod and the non-ringed graft.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 5 years before it stopped.
- 26 participants enrolled.
- Results were posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- W.L.Gore & Associates
- Sponsor type
- Industry
- Conditions
- Kidney Failure, Chronic; Renal Dialysis
- Interventions
- InnAVasc arteriovenous graft surgical implant
- Participants
- 26
- Sites
- 7
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.